These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 635674)

  • 1. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of komplamin in chronic ischemic heart disease].
    Serkova VK; Mikunis RI
    Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of ischemic heart disease with complamine].
    Kuz'ko NV
    Vrach Delo; 1981 Jan; (1):82-4. PubMed ID: 7010784
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS
    Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
    Mensen H
    Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the efficacy of xavin treatment of ischemic heart disease].
    Pomerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1978 Mar; 18(3):36-43. PubMed ID: 347136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE
    Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complamine in combination with methionine in the treatment of parapsoriasis].
    Orazymbetova ZhA
    Vestn Dermatol Venerol; 1978 Mar; (3):65-8. PubMed ID: 654516
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of complamin in some dermatoses].
    Verbenko EV; Goncharova LI; Petrova IL; Shamina GE
    Vestn Dermatol Venerol; 1975 Aug; (8):77-80. PubMed ID: 126606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE; Kessel ME
    Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative effectiveness of the local use of sodium nitrite, platyphylline and complamine in treating optic atrophy].
    Shpak NI; Salenko SV
    Oftalmol Zh; 1984; (5):294-7. PubMed ID: 6504461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cosaldon retard in the treatment of optic neuritis and macular degeneration].
    Myszka A
    Klin Oczna; 1979; 81(2):161-2. PubMed ID: 439725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of complamin in nephrological practice].
    Mamikonian RS; Barsegian BA; Tumanian AM; Arutiunian VM; Basmadzhian NM
    Zh Eksp Klin Med; 1979; 19(4):62-7. PubMed ID: 506579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of the local use of komplamin and ATP in treating patients with primary and secondary optic atrophy].
    Shpak NI; Fedorova LI; Savko VV; Konovalova NV
    Oftalmol Zh; 1985; (3):159-62. PubMed ID: 4011098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.